These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 6490095)

  • 1. Anti-tumour cytotoxin from macrophages: no correlation between cytotoxin adsorption by tumour cell lines and their cytotoxin susceptibility.
    Matthews N
    Immunology; 1984 Nov; 53(3):537-43. PubMed ID: 6490095
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of human monocyte killing of tumour cells of antibody raised against an extracellular monocyte cytotoxin.
    Matthews N
    Immunology; 1983 Feb; 48(2):321-7. PubMed ID: 6337089
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anti-tumour cytotoxin produced by human monocytes: studies on its mode of action.
    Matthews N
    Br J Cancer; 1983 Sep; 48(3):405-10. PubMed ID: 6615700
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human monocyte cytotoxin is not identical with lymphoblastoid lymphotoxin.
    Matthews N
    Eur J Immunol; 1985 Mar; 15(3):311-3. PubMed ID: 3872220
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interleukin 4 receptor on human lung cancer: a molecular target for cytotoxin therapy.
    Kawakami M; Kawakami K; Stepensky VA; Maki RA; Robin H; Muller W; Husain SR; Puri RK
    Clin Cancer Res; 2002 Nov; 8(11):3503-11. PubMed ID: 12429641
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Production of an anti-tumour cytotoxin by human monocytes.
    Matthews N
    Immunology; 1981 Sep; 44(1):135-42. PubMed ID: 7275181
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analysis of antitumor activity of an interleukin-13 (IL-13) receptor-targeted cytotoxin composed of IL-13 antagonist and Pseudomonas exotoxin.
    Kioi M; Kawakami K; Puri RK
    Clin Cancer Res; 2004 Sep; 10(18 Pt 1):6231-8. PubMed ID: 15448012
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification and characterization of interleukin-13 receptor in human medulloblastoma and targeting these receptors with interleukin-13-pseudomonas exotoxin fusion protein.
    Joshi BH; Leland P; Puri RK
    Croat Med J; 2003 Aug; 44(4):455-62. PubMed ID: 12950150
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antimicrobial effects of a macrophage-derived cytotoxin from the serum of BCG-primed rabbits (tumour necrosis serum).
    Neale ML; Matthews N
    J Med Microbiol; 1984 Apr; 17(2):211-3. PubMed ID: 6368832
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The cell surface of Aeromonas salmonicida determines in vitro survival in cultured brook trout (Salvelinus fontinalis) peritoneal macrophages.
    Daly JG; Kew AK; Moore AR; Olivier G
    Microb Pathog; 1996 Dec; 21(6):447-61. PubMed ID: 8971685
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Malarial parasites and tumour cells are killed by the same component of tumour necrosis serum.
    Taverne J; Matthews N; Depledge P; Playfair JH
    Clin Exp Immunol; 1984 Aug; 57(2):293-300. PubMed ID: 6467675
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interleukin-13 receptor alpha2 chain: a potential biomarker and molecular target for ovarian cancer therapy.
    Kioi M; Kawakami M; Shimamura T; Husain SR; Puri RK
    Cancer; 2006 Sep; 107(6):1407-18. PubMed ID: 16902988
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Cytotoxins from phagocytes].
    Yamazaki M
    Gan To Kagaku Ryoho; 1987 Jun; 14(6 Pt 2):2083-8. PubMed ID: 2440385
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Internalization property of interleukin-4 receptor alpha chain increases cytotoxic effect of interleukin-4 receptor-targeted cytotoxin in cancer cells.
    Kawakami K; Kawakami M; Leland P; Puri RK
    Clin Cancer Res; 2002 Jan; 8(1):258-66. PubMed ID: 11801567
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lysis of a broad range of epithelial tumour cells by human gamma delta T cells: involvement of NKG2D ligands and T-cell receptor- versus NKG2D-dependent recognition.
    Wrobel P; Shojaei H; Schittek B; Gieseler F; Wollenberg B; Kalthoff H; Kabelitz D; Wesch D
    Scand J Immunol; 2007; 66(2-3):320-8. PubMed ID: 17635809
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Functional and structural changes of porcine alveolar macrophages induced by sublytic doses of a heat-labile, hemolytic, cytotoxic substance produced by Actinobacillus pleuropneumoniae.
    Tarigan S; Slocombe RF; Browning GF; Kimpton W
    Am J Vet Res; 1994 Nov; 55(11):1548-57. PubMed ID: 7879978
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Verotoxin sensitivity of ECV304 cells in vitro and in vivo in a xenograft tumour model: VT1 as a tumour neovascular marker.
    Heath-Engel HM; Lingwood CA
    Angiogenesis; 2003; 6(2):129-41. PubMed ID: 14739619
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Morphological and intracellular alterations induced by Serratia marcescens cytotoxin.
    Carbonell GV; Falcón R; Yamada AT; da Fonseca BA; Yano T
    Res Microbiol; 2004; 155(1):25-30. PubMed ID: 14759705
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro production of rabbit macrophage tumor cell cytotoxin.
    Fisch H; Gifford GE
    Int J Cancer; 1983 Jul; 32(1):105-12. PubMed ID: 6862689
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Binding of cytotoxin P4 from Naja nigricollis nigricollis to B16F10 melanoma and WEHI-3B leukemia cells.
    Borkow G; Chaim-Matyas A; Ovadia M
    FEMS Microbiol Immunol; 1992 Sep; 5(1-3):139-45. PubMed ID: 1419110
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.